BSYI (Biosyntech) Stock Based Compensation: $0.27 Mil (TTM As of Dec. 2009)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosyntech Stock Based Compensation?

Biosyntech BSYI Stock Based Compensation is $0.27 Mil as of Dec. 2009.

Biosyntech's Stock Based Compensation for the three months ended in Dec. 2009 was $-0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2009 was $0.27 Mil.

Biosyntech Stock Based Compensation Related Terms

Biosyntech Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Biosyntech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Stock Based Compensation Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.00 0.17 0.10 -0.00

Biosyntech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.27 Mil.

What does a Stock Based Compensation of $0.27 Mil mean?
Biosyntech (BSYI) has a Stock Based Compensation of $0.27 Mil as of Dec. 2009. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Biosyntech and its competitors.
Is Biosyntech's Stock Based Compensation too high?
Biosyntech's current Stock Based Compensation is $0.27 Mil.
How does Biosyntech's Stock Based Compensation compare to NSPX and HSTC?
Biosyntech's Stock Based Compensation of $0.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Biosyntech and its competitors. Biosyntech's current Stock Based Compensation is $0.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosyntech stock overvalued right now?
Biosyntech (BSYI) has a current Stock Based Compensation of $0.27 Mil. The current Stock Based Compensation is $0.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Biosyntech (BSYI), the current Stock Based Compensation is $0.27 Mil as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.